October 2019

Feature

Plastibytes

A Novel Technique for Augmenting Venous Outflow in the Superior Gluteal Artery Perforator (SGAP) Flap

10/21/2019

Katherine H. Carruthers, MD, MS,^a Ergun Kocak, MD, MS,^b Pankaj Tiwari, MD,^b and Shunsuke Yoshida, MD^b

Katherine H. Carruthers, MD, MS,a Erg...

A method for augmenting venous outflow in the SGAP flap in the setting of autologous breast reconstruction is reported.

A method for augmenting venous...

10/21/2019

ePlasty

Research Reports

Use of Biomarker Testing in Lung Cancer Among Puerto Rico and Florida Physicians: Results of a Comparative Study

10/18/2019

Teresita Muñoz-Antonia, PhD

Vani N Simmons, PhD

Steven K Sutton, PhD

Matthew B Schabath, PhD

Iffat Alam

Alberto Chiappori, MD

Gwendolyn P Quinn, PhD

Abstract: Biomarker-driven therapies are the gold standard of treatment in lung cancer. Recent studies suggest a higher prevalence of specific targetable biomarkers among Hispanic/Latinos (H/L) than non-Hispanic...

...

10/18/2019

Journal of Clinical Pathways

Research Reports

Development of a Low Resource Tool for Optimizing Head and Neck Cancer Treatment Delivery Within an Integrated Health Care Delivery System

10/18/2019

Caroline Hudson, MD

David C Wilde, MD

Andrew T Huang, MD

David Hernandez, MD

Anita L Sabichi, MD

George Chen, MD

Peter Gerngross, DDS

Banner Logan, DDS, MD

Ricky Morlen, DMD

Scott Charnitsky, PA

Robert Parke, MD

Vlad C Sandulache, MD, PhD

Abstract: The Veterans Health Administration is the largest nationally integrated health care delivery system in the United States, making it an ideal environment for development of tools designed to streamline cancer diagnosis and...

Abstract: The Veterans...

10/18/2019

Journal of Clinical Pathways

Column

Editor's Page

Biomarker Testing and Prospective Tracking Tools

10/18/2019

Winston Wong, PharmD, Editor-in-Chief

Even though researchers are making progress every day, the precision medicine approach to cancer treatment is not yet part of routine care. Another strategy that can contribute to more personalized medicine is the...

Even...

10/18/2019

Journal of Clinical Pathways

Editorial

Potential or Unnecessary Burdens and Challenges for Practices Under Proposed CMS Radiation Oncology Model

10/18/2019

Nicolas Ferreyros, Managing Director, Community Oncology Alliance

In July 2019, the Centers for Medicare & Medicaid Services (CMS) proposed a mandatory Radiation Oncology (RO) Model that would require participation to test whether prospective site neutral, episode-based...

In...

10/18/2019

Journal of Clinical Pathways

Business of Pathways

Broadening the Value Assessment Paradigm: Including the Value of Hope and the Value of Insurance

10/18/2019

Sean McElligott, MS

Ira Klein, MD, MBA, FACP—Column Editor

*/ /*-->*/ While social media is all about sharing, very little personal preference data makes its way into health plan contracting around specific interventions and pathway programs today. As a result, the...

...

10/18/2019

Journal of Clinical Pathways

News

Conference Coverage

2019 Oncology Clinical Pathways Congress

10/18/2019

JCP Editors

Now in its fourth year, the Oncology Clinical Pathways Congress (OCPC) serves as a forum for oncology care professionals interested in utilizing clinical pathways as a tool to facilitate more value-based care...

Now...

10/18/2019

Journal of Clinical Pathways

Conference Coverage

European Society of Medical Oncology Annual Congress 2019

10/18/2019

JCP Editors

p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; text-align: justify; line-height: 12.0px; font: 27.0px Helvetica} p.p2 {margin: 0.0px 0.0px 0.0px 0.0px; text-align: justify; line-height: 12.0px; font: 10.0px Helvetica} p.p3...

p.p1...

10/18/2019

Journal of Clinical Pathways

Insights

Interview

Standardized Cancer Treatment at University Hospitals Seidman Cancer Center

10/18/2019

JCP Editors

Journal of Clinical Pathways (JCP) spoke with faculty at the University Hospitals Seidman Cancer Center, Cleveland, OH, regarding their unique positioning for cancer treatment in the greater Cleveland area and within...

...

10/18/2019

Journal of Clinical Pathways

Tools and Resources

Tools for Transformation

Contemplating the Future of Oncology Pathways

10/18/2019

Gordon Kuntz—Column Editor

Gordon Kuntz is a health care consultant and strategic advisor with over 30 years’ experience in a multitude of health care settings, working with payers and providers, and in technology and strategy. He began his...

Gordon...

10/18/2019

Journal of Clinical Pathways

Current Issue

June 2024

Volume 10

Issue 3

Current Issue

Issue Archive

Special Reports

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Winston Wong, PharmD

Gordon Kuntz

Robin T Zon, MD, FACP, FASCO

2021 Care Pathways Working Group

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

$Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma$

Special Report

Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma

01/14/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Editorial Correspondence

October 2019

Feature

Column

News

Insights

Tools and Resources

Current Issue

Special Reports

Subscribe

Volume 5

Specialties

Events

Year Round Education

HMP Global Products